Three-dimensional structure of a Nanobody® (modeled on the VHH with pdb-code 1U0Q, Cambillau et al). The target molecule is recognized by the surface formed by three hypervariable regions located at the top of the molecule (in green, cyan and blue). Hallmarks, amino acid residues that further differentiate a camelid VHH from a human VH, can be located at different positions within the framework regions, and here are coloured red, pink and magenta.

Home News room Press releases
Press Releases

2008

28/05/2008
ABLYNX ANNOUNCES INITIATION OF A PHASE IB STUDY IN PATIENTS FOR ALX-0081 AND PROVIDES A BUSINESS UPDATE FOR THE FIRST QUARTER 2008
NL

27/04/2008
ABLYNX ANNOUNCES SENIOR MANAGEMENT CHANGE
NL

28/02/2008
ABLYNX ANNOUNCES FULL YEAR RESULTS FOR 2007
NL

21/02/2008
ABLYNX WILL ANNOUNCE FULL YEAR RESULTS FOR 2007 ON 28 FEBRUARY 2008
NL

19/02/2008
ABLYNX RECEIVES MILESTONE PAYMENT FROM NANOBODYŽ DISCOVERY AND DEVELOPMENT ALLIANCE
NL

05/02/2008
ABLYNX RESPONDS TO REQUEST FOR ARBITRATION FROM DOMANTIS
NL




 

News archive

Email alerts

If you would like to receive updates on the company news, please
click here